Silexion Therapeutics Corp (SLXN)

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $8.41 million. The enterprise value is $11.71 million.

Market Cap	8.41M
Enterprise Value	11.71M

Important Dates

The next estimated earnings date is Wednesday, May 21, 2025, before market open.

Earnings Date	May 21, 2025
Ex-Dividend Date	n/a

Share Statistics

SLXN has 8.41 million shares outstanding. The number of shares has increased by 3,666.05% in one year.

Current Share Class	8.41M
Shares Outstanding	8.41M
Shares Change (YoY)	+3,666.05%
Shares Change (QoQ)	+150.35%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	6.49%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-2.11
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio	0.64
Quick Ratio	0.34
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-465.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-193.54%
Return on Invested Capital (ROIC)	-427.70%
Return on Capital Employed (ROCE)	1,904.70%
Revenue Per Employee	n/a
Profits Per Employee	-$1.17M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SLXN has paid $10,000 in taxes.

Income Tax	10,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.06
52-Week Price Change	n/a
50-Day Moving Average	1.03
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.05
Average Volume (20 Days)	3,643,671

Short Selling Information

The latest short interest is 775,098, so 9.21% of the outstanding shares have been sold short.

Short Interest	775,098
Short Previous Month	263,179
Short % of Shares Out	9.21%
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.57M
Pretax Income	n/a
Net Income	-16.44M
EBITDA	-12.55M
EBIT	-12.57M
Earnings Per Share (EPS)	-$26.36

Balance Sheet

The company has $1.19 million in cash and $4.49 million in debt, giving a net cash position of -$3.30 million or -$0.39 per share.

Cash & Cash Equivalents	1.19M
Total Debt	4.49M
Net Cash	-3.30M
Net Cash Per Share	-$0.39
Equity (Book Value)	-3.99M
Book Value Per Share	-2.16
Working Capital	-1.27M

Cash Flow

In the last 12 months, operating cash flow was -$8.40 million and capital expenditures -$22,000, giving a free cash flow of -$8.42 million.

Operating Cash Flow	-8.40M
Capital Expenditures	-22,000
Free Cash Flow	-8.42M
FCF Per Share	-$1.00

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,666.05%
Shareholder Yield	-3,666.05%
Earnings Yield	-195.63%
FCF Yield	-100.15%

Analyst Forecast

The average price target for SLXN is $5.00, which is 400.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	400.55%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 29, 2024. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Nov 29, 2024
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1